Literature DB >> 1786262

Clonidine as a sensitizing agent in the forced swimming test for revealing antidepressant activity.

M Bourin1, M C Colombel, M Malinge, J Bradwejn.   

Abstract

The forced swimming test (FST) in mice has failed to predict antidepressant activity for drugs having beta adrenoreceptor agonist activity and for serotonin uptake inhibitors. We investigated the potential for clonidine to render the FST sensitive to antidepressants by using a behaviorally inactive dose of this agent (0.1 mg/kg). All antidepressants studied (tricyclics, 5-HT uptake inhibitors, iprindole, mianserin, viloxazine, trazodone) showed either activity at lower doses or activity at previously inactive doses. The effect appeared specific because it did not appear with drugs other than antidepressants (diazepam, chlorpromazine, sulpiride, atropine), except for amphetamine and apomorphine which have a strong effect on the dopaminergic system. The use of behaviorally subactive doses of clonidine may thus provide an important means of increasing the sensitivity of the forced swimming test.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1786262      PMCID: PMC1188336     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  15 in total

1.  Reversal of behavioral depression by infusion of an alpha-2 adrenergic agonist into the locus coeruleus.

Authors:  P G Simson; J M Weiss; L J Hoffman; M J Ambrose
Journal:  Neuropharmacology       Date:  1986-04       Impact factor: 5.250

2.  Additive effects of clonidine and antidepressant drugs in the mouse forced-swimming test.

Authors:  M Malinge; M Bourin; M C Colombel; C Larousse
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 3.  Is the forced swimming test a suitable model for revealing antidepressant activity?

Authors:  F Borsini; A Meli
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 4.  The validity of animal models of depression.

Authors:  P Willner
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  A 2-amino-2-oxazoline derivative as an antidepressant in mice.

Authors:  M Bourin; M H Creuzet; C Jarry; M C Colombel
Journal:  Arzneimittelforschung       Date:  1988-05

6.  Dihydropyridine calcium channel antagonists reduce immobility in the mouse behavioral despair test; antidepressants facilitate nifedipine action.

Authors:  E Mogilnicka; A Czyrak; J Maj
Journal:  Eur J Pharmacol       Date:  1987-06-26       Impact factor: 4.432

7.  Minaprine, a new drug with antidepressant properties.

Authors:  K Bizière; P Worms; J P Kan; P Mandel; S Garattini; R Roncucci
Journal:  Drugs Exp Clin Res       Date:  1985

8.  [The new versus the old antidepressant drugs: a comparative study of their psychopharmacological profiles (author's transl)].

Authors:  M Bourin; A J Puech; R Chermat; L Doare; M Poncelet; P Simon
Journal:  Encephale       Date:  1981       Impact factor: 1.291

9.  Involvement of alpha- and beta 1-adrenergic mechanisms in the immobility-reducing action of desipramine in the forced swimming test.

Authors:  Y Kitada; T Miyauchi; Y Kanazawa; H Nakamichi; S Satoh
Journal:  Neuropharmacology       Date:  1983-09       Impact factor: 5.250

Review 10.  Clinical pharmacokinetics of bupropion: a review.

Authors:  A A Lai; D H Schroeder
Journal:  J Clin Psychiatry       Date:  1983-05       Impact factor: 4.384

View more
  11 in total

Review 1.  Forced swimming test in mice: a review of antidepressant activity.

Authors:  Benoit Petit-Demouliere; Franck Chenu; Michel Bourin
Journal:  Psychopharmacology (Berl)       Date:  2004-11-18       Impact factor: 4.530

Review 2.  Rate-dependent behavioral effects of stimulation of central motoric alpha(1)-adrenoceptors: hypothesized relation to depolarization blockade.

Authors:  Eric A Stone; David Quartermain
Journal:  Psychopharmacology (Berl)       Date:  2005-01-12       Impact factor: 4.530

3.  The effect of sympathetic antagonists on the antidepressant action of alprazolam.

Authors:  Ra Al-Tubuly; Sm Aburawi; Ea Alghzewi; Zm Gorash; S Errwami
Journal:  Libyan J Med       Date:  2008-06-01       Impact factor: 1.657

4.  Antidepressant-like effects of guanfacine and sex-specific differences in effects on c-fos immunoreactivity and paired-pulse ratio in male and female mice.

Authors:  Yann S Mineur; Matthew P Bentham; Wen-Liang Zhou; Margreet E Plantenga; Sherry A McKee; Marina R Picciotto
Journal:  Psychopharmacology (Berl)       Date:  2015-07-07       Impact factor: 4.530

5.  Effect of potassium channel modulators in mouse forced swimming test.

Authors:  N Galeotti; C Ghelardini; B Caldari; A Bartolini
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

6.  Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?

Authors:  C Sánchez; E Meier
Journal:  Psychopharmacology (Berl)       Date:  1997-02       Impact factor: 4.530

7.  Animal model of menopausal depressive-like state in female mice: prolongation of immobility time in the forced swimming test following ovariectomy.

Authors:  Naoko Bekku; Hiroyuki Yoshimura
Journal:  Psychopharmacology (Berl)       Date:  2005-10-14       Impact factor: 4.530

8.  The additive effects of quinine on antidepressant drugs in the forced swimming test in mice.

Authors:  W Y Guo; K G Todd; M Bourin; M Hascoet
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

Review 9.  The behavioral actions of lithium in rodent models: leads to develop novel therapeutics.

Authors:  Kelley C O'Donnell; Todd D Gould
Journal:  Neurosci Biobehav Rev       Date:  2007-04-13       Impact factor: 8.989

10.  Clonidine potentiates the effects of tranylcypromine, phenelzine and two analogues in the forced swimming test in mice.

Authors:  Michel Bourin; Martine Hascoët; Marie Claude Colombel; Ronald T Coutts; Glen B Baker
Journal:  J Psychiatry Neurosci       Date:  2002-05       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.